1. Home
  2. LBRX vs FBIZ Comparison

LBRX vs FBIZ Comparison

Compare LBRX & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LBRX

LB Pharmaceuticals Inc

N/A

Current Price

$23.80

Market Cap

602.6M

Sector

Health Care

ML Signal

N/A

Logo First Business Financial Services Inc.

FBIZ

First Business Financial Services Inc.

HOLD

Current Price

$58.23

Market Cap

462.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRX
FBIZ
Founded
2015
1909
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
602.6M
462.2M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
LBRX
FBIZ
Price
$23.80
$58.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$49.00
$65.00
AVG Volume (30 Days)
187.1K
27.1K
Earning Date
06-25-2026
01-29-2026
Dividend Yield
N/A
2.32%
EPS Growth
N/A
14.32
EPS
N/A
5.94
Revenue
N/A
$159,972,000.00
Revenue This Year
N/A
$15.69
Revenue Next Year
N/A
$8.47
P/E Ratio
N/A
$9.88
Revenue Growth
N/A
10.61
52 Week Low
$13.36
$42.18
52 Week High
$24.95
$60.54

Technical Indicators

Market Signals
Indicator
LBRX
FBIZ
Relative Strength Index (RSI) 58.82 57.11
Support Level $23.52 $58.75
Resistance Level $24.84 $60.16
Average True Range (ATR) 1.47 1.51
MACD 0.13 -0.00
Stochastic Oscillator 79.07 70.20

Price Performance

Historical Comparison
LBRX
FBIZ

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: